Your Location:
Home >
Browse articles >
Jianpi Xiaoai Prescription Ameliorates Chemotherapy Resistance in Colon Cancer by Targeting FGF2 to Inhibit PI3K/Akt Signaling Pathway
Updated:2026-02-28
    • Jianpi Xiaoai Prescription Ameliorates Chemotherapy Resistance in Colon Cancer by Targeting FGF2 to Inhibit PI3K/Akt Signaling Pathway

      Enhanced Publication
    • JIAN Xiaolan , NING Kangwen , YANG Jiaxiang , KOU Shenglan , KUANG Wanting , WANG Ziqi , TAN Yuqin , ZENG Puhua , TAN Lingjuan , PENG Wei
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 6, Pages: 120-130(2026)
    • DOI: 10.13422/j.cnki.syfjx.20251123     

      CLC:
    • Revised:2025-03-17 ,

      Accepted:18 March 2025 ,

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 5 ) Tabs( 9 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

240

Views

180

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Effect of Jianpi Xiaoai Prescription on Expression of Metastasis-related Factors in Tumor Microenvironment of Nude Mouse Model of Liver Metastasis of Colon Cancer
Effect of Jianpi Xiao' ai Prescription on Akt/mTOR Signaling Pathways in Colorectal Cells
Chinese Medicine in Treatment of Colorectal Cancer by Regulating Hedgehog Signaling Pathway: A Review
Mechanisms of Zuojinwan in Inhibiting Tumor-associated Macrophage M2 Polarization Against Colorectal Cancer Through Regulation of TIPE1/PI3K/Akt Signaling Pathway
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway

Related Author

HE Weihua
DENG Lan
JIANG Yilan
Xiao-lan JIAN
Pu-hua ZENG
Yong-min LI
Xiao-ning TAN
Feng-jiao HE

Related Institution

Wuhan Hospital of Traditional Chinese Medicine
Affiliated Hospital of Jiangxi University of Chinese Medicine
Affiliated Hospital of Hunan Academy of Chinese Medicine
Innovative Platform of Anti-tumor Chinese Drugs, Hunan Key Laboratory of Chinese Medicine Oncology, The Affiliated Hospital of Hunan Academy of Chinese Medicine
Henan University of Chinese Medicine